Federal Register / Vol. 74, No. 39 / Monday, March 2, 2009 / Notices 9085 

B. Annual Reporting Burden 

Respondents: 27,000. 

Responses Per Respondent: 32. 

Annual Responses: 864,000. 

Hours Per Response: .55. 

Total Burden Hours: 475,200. 

OBTAINING COPIES OF 

PROPOSALS: Requesters may obtain a 

copy of the information collection 

documents from the General Services 

Administration, FAR Secretariat (VPR), 

Room 4041, Washington, DC 20405, 

telephone (202) 501–4755. Please cite 

OMB Control No. 9000–0010, Progress 

Payments, in all correspondence. 

Dated: February 19, 2009. 

Al Matera, 

Director, Contract Policy Division. 

[FR Doc. E9–4340 Filed 2–27–09; 8:45 am] 

BILLING CODE 6820–EP–S 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

DoD Medicare-Eligible Retiree Health 

Care Board of Actuaries 

AGENCY: Department of Defense. 

ACTION: Notice of meeting. 

SUMMARY: Under the provisions of the 

Federal Advisory Committee Act of 

1972 (5 U.S.C., Appendix, as amended), 

the Government in the Sunshine Act of 

1976 (5 U.S.C. 552b, as amended), and 

41 CFR 102–3.150, the Department of 

Defense announces that the following 

Federal advisory committee meeting of 

the DoD Medicare-Eligible Retiree 

Health Care Board of Actuaries will take 

place: 

DATES: Friday, July 31, 2009 from 1–5 

p.m. 

ADDRESSES: 4040 N. Fairfax Drive, Suite 

270, Arlington, VA 22203. 

FOR FURTHER INFORMATION CONTACT: 

Margot Kaplan, 703–696–7404. 

SUPPLEMENTARY INFORMATION: Purpose of 

the Meeting: The purpose of the meeting 

is to execute the provisions of Chapter 

56, Title 10, United States Code (10 

U.S.C. 1114 et seq). The Board shall 

review DoD actuarial methods and 

assumptions to be used in the valuation 

of benefits under DoD retiree health care 

programs for Medicare-eligible 

beneficiaries. 

Agenda 

Meeting objective (Board). 

Approve actuarial assumptions and 

methods needed for calculating: 

FY 2011 per capita full-time and parttime normal cost amounts. 

September 30, 2008 unfunded 

liability (UFL). 

October 1, 2009 Treasury UFL 

amortization payment and normal cost 

payment. 

Trust Fund Update (DFAS). 

Medicare-Eligible Retiree Health Care 

Fund Update (Tricare Management 

Activity). 

September 30, 2007 Actuarial 

Valuation Results (DoD Office of the 

Actuary). 

September 30, 2008 Actuarial 

Valuation (DoD Office of the Actuary). 

Decisions (Board). 

Approve actuarial assumptions and 

methods needed for calculating: 

FY 2011 per-capita full-time and parttime normal cost amounts. 

September 30, 2008 UFL. 

October 1, 2009 Treasury UFL 

amortization payment and normal cost 

payment. 

Public’s Accessibility to the Meeting: 

Pursuant to 5 U.S.C. 552b and 41 CFR 

102–3.140 through 102–3.165 and the 

availability of space, this meeting is 

open to the public. Seating is on a firstcome basis. 

Committee’s Designated Federal 

Officer or Point of Contact: Persons 

desiring to attend the DoD MedicareEligible Retiree Health Care Board of 

Actuaries meeting or make an oral 

presentation or submit a written 

statement for consideration at the 

meeting, must notify Margot Kaplan at 

703–696–7404 by July 10, 2009. For 

further information contact Margot 

Kaplan at the DoD Office of the Actuary, 

4040 N. Fairfax Drive, Suite 308, 

Arlington, VA 22203. 

Dated: February 24, 2009. 

Patricia L. Toppings, 

OSD Federal Register, Liaison Officer, 

Department of Defense. 

[FR Doc. E9–4326 Filed 2–27–09; 8:45 am] 

BILLING CODE 5001–06–P 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

Meeting of the Uniform Formulary 

Beneficiary Advisory Panel 

AGENCY: Department of Defense, 

Assistant Secretary of Defense (Health 

Affairs). 

ACTION: Notice of meeting. 

SUMMARY: Under the provisions of the 

Federal Advisory Committee Act of 

1972 (5 U.S.C., Appendix, as amended) 

and the Sunshine in the Government 

Act of 1976 (U.S.C. 552b, as amended) 

the Department of Defense announces 

the following Federal Advisory 

Committee Meeting of the Uniform 

Formulary Beneficiary Advisory Panel 

(hereafter referred to as the Panel). 

DATES: March 26, 2009 from 8 a.m. to 4 

p.m. 

ADDRESSES: Naval Heritage Center 

Theater, 701 Pennsylvania Avenue, 

NW., Washington, DC 20004. 

FOR FURTHER INFORMATION CONTACT: 

LtCol Thomas Bacon, Designated 

Federal Officer, Uniform Formulary 

Beneficiary Advisory Panel, Skyline 5, 

Suite 810, 5111 Leesburg Pike, Falls 

Church, VA 22041–3206; Telephone: 

(703) 681–2890; Fax: (703) 681–1940; Email Address: baprequests@tma.osd.mil. 

SUPPLEMENTARY INFORMATION: 

Purpose of Meeting: The Panel will 

review and comment on 

recommendations made to the Director, 

TRICARE Management Activity, by the 

Pharmacy and Therapeutics (P&T) 

Committee regarding the Uniform 

Formulary. 

Meeting Agenda: Sign-In; Welcome 

and Opening Remarks; Public Citizen 

Comments; Scheduled Therapeutic 

Class Reviews—Long-acting beta 

agonists (LABAs); Inhaled 

corticosteroids (ICS), Combination longacting beta agonists/inhaled steroids 

(LABA/ICS Combos) and Designated 

newly approved drugs; Panel 

Discussions and Vote, and comments 

following each therapeutic class review. 

Meeting Accessibility: Pursuant to 5 

U.S.C. 552b, as amended, and 41 CFR 

102–3.140 through 102–3.165, and the 

availability of space this meeting is 

open to the public. Seating is limited 

and will be provided only to the first 

220 people signing in. All persons must 

sign in legibly. 

Administrative Work Meeting: Prior to 

the public meeting the Panel will 

conduct an Administrative Work 

Meeting from 7 a.m. to 7:50 a.m. to 

discuss administrative matters of the 

Panel. The Administrative Work 

Meeting will be held at the Naval 

Heritage Center Conference Room, 701 

Pennsylvania Avenue, NW., Washington 

DC 20004. Pursuant to 41 CFR 102– 

3.160, the Administrative Work Meeting 

will be closed to the public. 

Written Statements: Pursuant to 41 

CFR 102–3.105(j) and 102–3.140, the 

public or interested organizations may 

submit written statements to the 

membership of the Panel at any time or 

in response to the stated agenda of a 

planned meeting. Written statements 

should be submitted to the Panel’s 

Designated Federal Officer; the 

Designated Federal Officer’s contact 

information can be obtained from the 

GSA’s FACA Database—https:// 

www.fido.gov/facadatabase/public.asp. 

Written statements that do not pertain 

to the scheduled meeting of the Panel 

may be submitted at any time. However, 


erowe on PROD1PC63 with NOTICES